Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT02203006

HIV Patients Cohort

The purpose of this study is to improve our knowledge concerning HIV infection, treated or not, in the current conditions of care to optimize it.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Patients Affected by the HIV Infections

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital Hôtel Dieu

Paris, 75004, France

About this study

Since the arrival of highly active tritherapies, HIV infection became mainly an ambulatory chronic pathology centred on a long term care taking into account the complication of long-term treatment as well as the arisen of new problem bound to a prolonged survival and ageing. So the care is more and more in a prevention and screening approach with in particular the care of metabolic and cardiovascular complication due to antiretroviral treatment.

As a reorganization of the coverage of the HIV infected people take place on the Hotel Dieu Hospital it thus seems important to double this care optimization with a clinical research side. This will be done in constituting an HIV patient cohort including a blood sample collection to contribute to the vigilance of the complication to due the infection.

Our ultimate objective is to optimize the selection of the treatment. It is important to do it to be able to have, on many years duration, precise clinical information and biological sample allowing to realize later some assay and analyse the influence of some genetic markers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged ≥18 years old,
  • Patients with an HIV infection
  • patients having given their written informed consent.

Treatment and study plan

OVIHD

Biological

7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.

Other names: Blood sample

Primary outcomes

  1. HIV infection

    Time frame: 10 years

    The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)

Secondary outcomes

  1. Comorbidity and complication in HIV infected patients

    Time frame: 10 years

    The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)

  2. efficiency of the current antiretroviral therapeutic diets

    Time frame: 10 years

    The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)

  3. Blood sample collection

    Time frame: 10 years

    To put in relation the clinical-biological relevant biological or genetic data of the follow-up a blood sample will be constituted. 7 ml will be taken to each patient and kept in a collection

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Constitution of an Open Monocentric Cohort of HIV Infected Patients

Acronym: OVIHD

Important dates

Study start
2011
Primary completion
2030
Study completion
2030
First posted
Jul 29, 2014
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.